Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 27 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 11198694

    HDAC6 inhibitors, with improved solubility and their uses

    Universität Regensburg · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  2. US 11191750

    Use of mTOR inhibitors for treatment of familial adenomatous polyposis

    The Board of Regents of the University of Texas System · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  3. US 11192861

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  4. US 11192907

    Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same

    QUANTUM GENOMICS · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  5. US 11191758

    Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors

    Uniwersytet Jagiellonski Collegium Medicum · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  6. US 11186576

    Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitors

    Aurigene Discovery Technologies Limited · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  7. US 11180484

    Pyrazole derivatives as plasma kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  8. US 11180494

    Substituted amino acids as integrin inhibitors

    Pliant Therapeutics, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  9. US 11180499

    Phosphodiesterase inhibitors

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  10. US 11180466

    2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors

    University College Cardiff Consultants Limited · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  11. US 11179400

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  12. US 11180483

    Substituted reverse pyrimidine Bmi-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  13. US 11179394

    Method for treating cancer using a combination of Chk1 and ATR inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  14. US 11173145

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

    The Board of Regents of the University of Texas System · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  15. US 11174219

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  16. US 11174232

    Substituted heterocyclyl derivatives as CDK inhibitors

    Aurigene Discovery Technologies Limited · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  17. US 11167004

    Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  18. US 11168082

    Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  19. US 11168083

    Inhibitors of Plasma Kallikrein and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  20. US 11168071

    Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  21. US 11166942

    Inhibitors of integrated stress response pathway

    PRAXIS BIOTECH LLC · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  22. US 2021338651

    METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS

    NEUROCRINE BIOSCIENCES INC [US] · Granted Nov 4, 2021 · Expires Oct 30, 2041

    granted
  23. US 11160810

    Fused imidazo-piperidine JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted
  24. US 11160800

    Methods of treatment using a JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted